Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery disease

Even though N6-methyladenosine (m6A) RNA modifications are increasingly being implicated in human disease, their mechanisms are not fully understood in smokers with coronary artery disease (CAD). Thirty m6A-related regulators’ expression (MRRE) in CAD individuals (smokers and non-smokers) were analy...

Full description

Saved in:
Bibliographic Details
Main Authors: Huanwei Zhuang, Hua Ouyang, Yangfei Peng, Shuji Gong, Kun Xiang, Le Chen, Jinlan Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Epigenetics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15592294.2024.2392400
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850169073273405440
author Huanwei Zhuang
Hua Ouyang
Yangfei Peng
Shuji Gong
Kun Xiang
Le Chen
Jinlan Chen
author_facet Huanwei Zhuang
Hua Ouyang
Yangfei Peng
Shuji Gong
Kun Xiang
Le Chen
Jinlan Chen
author_sort Huanwei Zhuang
collection DOAJ
description Even though N6-methyladenosine (m6A) RNA modifications are increasingly being implicated in human disease, their mechanisms are not fully understood in smokers with coronary artery disease (CAD). Thirty m6A-related regulators’ expression (MRRE) in CAD individuals (smokers and non-smokers) were analyzed from GEO. Support Vector Machine, random forest, and nomogram models were constructed to assess its clinical value. Consensus clustering, principal component analysis, and ssGSEA were used to construct a full picture of m6A-related regulators in smokers with CAD. Oxygen-glucose deprivation (OGD) and qRT-PCR were used to validate hypoxia’s effect on MRRE. A comparison between smokers with CAD and controls revealed lower expression levels of RBM15B, YTHDC2, and ZC3H13. Based on three key MRREs, all models showed good clinical value, and smokers with CAD were divided into two distinct molecular subgroups. The correlations were found between key MRRE and the degree of immune infiltration. Three key MRREs in HUVECs and FMC84 mouse cardiomyocytes were reduced in the OGD group. Through hypoxia, smoking might reduce the expression levels of RBM15B, YTHDC2, and ZC3H13 in smokers with CAD. Our findings provide an important theoretical basis for the treatment of smokers with CAD.
format Article
id doaj-art-1f33ffe4f3524164a0741001329ed497
institution OA Journals
issn 1559-2294
1559-2308
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Epigenetics
spelling doaj-art-1f33ffe4f3524164a0741001329ed4972025-08-20T02:20:49ZengTaylor & Francis GroupEpigenetics1559-22941559-23082024-12-0119110.1080/15592294.2024.2392400Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery diseaseHuanwei Zhuang0Hua Ouyang1Yangfei Peng2Shuji Gong3Kun Xiang4Le Chen5Jinlan Chen6Department of Cardiovascular Surgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, ChinaDepartment of Thoracic Surgery, ZhuJiang Hospital of Southern Medical University, Southern Medical University, Guangzhou, ChinaDepartment of Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, ChinaDepartment of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, ChinaEven though N6-methyladenosine (m6A) RNA modifications are increasingly being implicated in human disease, their mechanisms are not fully understood in smokers with coronary artery disease (CAD). Thirty m6A-related regulators’ expression (MRRE) in CAD individuals (smokers and non-smokers) were analyzed from GEO. Support Vector Machine, random forest, and nomogram models were constructed to assess its clinical value. Consensus clustering, principal component analysis, and ssGSEA were used to construct a full picture of m6A-related regulators in smokers with CAD. Oxygen-glucose deprivation (OGD) and qRT-PCR were used to validate hypoxia’s effect on MRRE. A comparison between smokers with CAD and controls revealed lower expression levels of RBM15B, YTHDC2, and ZC3H13. Based on three key MRREs, all models showed good clinical value, and smokers with CAD were divided into two distinct molecular subgroups. The correlations were found between key MRRE and the degree of immune infiltration. Three key MRREs in HUVECs and FMC84 mouse cardiomyocytes were reduced in the OGD group. Through hypoxia, smoking might reduce the expression levels of RBM15B, YTHDC2, and ZC3H13 in smokers with CAD. Our findings provide an important theoretical basis for the treatment of smokers with CAD.https://www.tandfonline.com/doi/10.1080/15592294.2024.2392400Coronary artery diseasesmokingN6-methyladenosine RNA modificationhypoxiaepigenetic modification
spellingShingle Huanwei Zhuang
Hua Ouyang
Yangfei Peng
Shuji Gong
Kun Xiang
Le Chen
Jinlan Chen
Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery disease
Epigenetics
Coronary artery disease
smoking
N6-methyladenosine RNA modification
hypoxia
epigenetic modification
title Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery disease
title_full Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery disease
title_fullStr Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery disease
title_full_unstemmed Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery disease
title_short Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery disease
title_sort expression patterns and clinical value of key m6a rna modification regulators in smoking patients with coronary artery disease
topic Coronary artery disease
smoking
N6-methyladenosine RNA modification
hypoxia
epigenetic modification
url https://www.tandfonline.com/doi/10.1080/15592294.2024.2392400
work_keys_str_mv AT huanweizhuang expressionpatternsandclinicalvalueofkeym6arnamodificationregulatorsinsmokingpatientswithcoronaryarterydisease
AT huaouyang expressionpatternsandclinicalvalueofkeym6arnamodificationregulatorsinsmokingpatientswithcoronaryarterydisease
AT yangfeipeng expressionpatternsandclinicalvalueofkeym6arnamodificationregulatorsinsmokingpatientswithcoronaryarterydisease
AT shujigong expressionpatternsandclinicalvalueofkeym6arnamodificationregulatorsinsmokingpatientswithcoronaryarterydisease
AT kunxiang expressionpatternsandclinicalvalueofkeym6arnamodificationregulatorsinsmokingpatientswithcoronaryarterydisease
AT lechen expressionpatternsandclinicalvalueofkeym6arnamodificationregulatorsinsmokingpatientswithcoronaryarterydisease
AT jinlanchen expressionpatternsandclinicalvalueofkeym6arnamodificationregulatorsinsmokingpatientswithcoronaryarterydisease